Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients
N Kamar, F Abravanel, O Marion, C Couat… - … England Journal of …, 2021 - Mass Medical Soc
N Kamar, F Abravanel, O Marion, C Couat, J Izopet, A Del Bello
New England Journal of Medicine, 2021•Mass Medical SocThree Covid-19 Vaccine Doses in Transplant Recipients Solid-organ transplant recipients
receiving immunosuppressive therapy appear to have a poor response to Covid-19
vaccination. A group of 101 consecutive transplant recipients received two doses of the
BNT162b2 vaccine 1 month apart and a third dose 2 months after the second dose; 40%
had antibodies after the second dose and 68% had antibodies after the third dose.
receiving immunosuppressive therapy appear to have a poor response to Covid-19
vaccination. A group of 101 consecutive transplant recipients received two doses of the
BNT162b2 vaccine 1 month apart and a third dose 2 months after the second dose; 40%
had antibodies after the second dose and 68% had antibodies after the third dose.
Three Covid-19 Vaccine Doses in Transplant Recipients
Solid-organ transplant recipients receiving immunosuppressive therapy appear to have a poor response to Covid-19 vaccination. A group of 101 consecutive transplant recipients received two doses of the BNT162b2 vaccine 1 month apart and a third dose 2 months after the second dose; 40% had antibodies after the second dose and 68% had antibodies after the third dose.
The New England Journal Of Medicine